Chin. J. Org. Chem. ›› 2015, Vol. 35 ›› Issue (6): 1310-1319.DOI: 10.6023/cjoc201412011 Previous Articles     Next Articles

Articles

杂环酮腙与类似物的合成及其对结核杆菌的抑制活性

李忠洲a, 赵升a, 李新军a, 王翠翠a, 姚璐璐a, 金瑞良b, 邹新琢a   

  1. a 华东师范大学化学系 上海 200241;
    b 同济大学附属上海肺科医院上海市结核病(肺)重点实验室 上海 200433
  • 收稿日期:2014-12-04 修回日期:2015-01-21 发布日期:2015-02-02
  • 通讯作者: 邹新琢 E-mail:xzzou@chem.ecnu.edu.cn

Synthesis and Anti-mycobacterial Activities of Heterocyclic Hydrazones and Their Bioisosteric Compounds

Li Zhongzhoua, Zhao Shenga, Li Xinjuna, Wang Cuicuia, Yao Lulua, Jin Ruiliangb, Zou Xinzhuoa   

  1. a Department of Chemistry, East China Normal University, Shanghai 200241;
    b Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433
  • Received:2014-12-04 Revised:2015-01-21 Published:2015-02-02

A total of 22 new heterocyclic hydrazones and their bioisosteric compounds were synthesized and evaluated for their activity against Mycobacterium tuberculosis, strain H37Rv. All newly synthesized compounds showed inhibitory activities. Among these compounds, (1E,4E)-1,5-bis(5-bromo-2-thiophenyl)-1,4-pentadiene-3-one-(1,4,5,6-tetrahydro-2-pyrimi- dimyl)-hydrazone (1d) showed the most effective anti-tubercular activity with MIC90 value of 2 μg/mL, and exhibited an excellent inhibitory activity against isoniazid-resistant strain 242, multidrug-resistant strain 2312, and extensively drug-resistant strain 1220 with MIC90 values of 0.25, 1.0 and 0.5 μg/mL, respectively.

Key words: heterocyclic hydrazone analogs, synthesis, Mycobacterium tuberculosis, anti-mycobacterial activity